Back to Top Skip to main content Skip to sub-navigation

Hepburn: DOD role in Operation Warp Speed was ‘transformative’

Medical technician getting a syringe ready to give a vaccine Crystal Tyler, pharmacy technician, prepares an injection for an Operation Warp Speed patient volunteer at Brooke Army Medical Center Fort Sam Houston, Texas, November 16, 2020. BAMC is one of five Defense Health Agency military medical treatment facilities participating in the Phase III trial to evaluate the vaccine under development by AstraZeneca as part of a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics. (Photo by Jason Edwards, Brooke Army Medical Center.)

Recommended Content:

COVID-19 Vaccine Efforts | Vaccine Trials | Coronavirus | COVID-19 Vaccine Toolkit

The director of the Department of Defense’s Operation Warp Speed told The Society of Federal Health Professionals that he is 'incredibly proud’ of the work his team has done with the Department of Health and Human Services in finding a vaccine for COVID-19. Dr. Matthew Hepburn’s praise for DOD came during a speech to the AMSUS virtual annual meeting Dec. 8.

The DOD’s role in Operations Warp Speed (OWS) was “transformative,” said Hepburn, OWS development lead, pointing to operational planning, logistics and supply chains, which “is in our DNA” at DOD. “It comes very naturally because that is what we do…and that has made all the difference,” he told the audience of more than 1,500 online attendees.

For example, he said DOD’s expertise in obtaining contracts quickly resulted in OWS getting “a really good deal in record time that was mutually beneficial” to the six vaccine manufacturers the joint operation decided to pursue for an approved vaccine for COVID-19. Those manufacturers are Pfizer, Moderna, AstraZeneca, Janssen, Novavax, and Sanofi.

“The Department of Defense’s unique contracting experience … and other transactions have allowed us to come from where we think are the right contacts to having long-term contracts,” Hepburn said.

Pfizer and Moderna have applied for emergency use authorization from the Food and Drug Administration. Pfizer’s application will be reviewed by an FDA advisory committee of vaccine experts Dec. 10, and Moderna’s application will be reviewed a week later. The FDA usually, but not always, accepts its advisory panels’ recommendations.

The FDA announced on Dec. 8 that its review of the Pfizer vaccine found it to be safe and efficacious, meeting the requirements for emergency use authorization. The vaccine showed a strong protective effect after the first of two doses, according to the FDA.

The OWS’ chief operating officer, Army Gen. Gustave Perna, “has been very clear that we will have trucks rolling within 24 hours of approval of the first vaccine,” Hepburn said.

Once the vaccine is first available to frontline health care workers and elderly care facilities, “we need you to tell our communities that this is just one layer of a multi-level strategy” to protect against COVID-19, he stated.

He urged the health care community “to convey a message that these vaccines are safe and efficacious, and that vaccination is important” as a counterpoint to widespread misinformation in the general public about vaccines and the need for vaccination against the disease.

Clinical trials for the candidate vaccines are ongoing and represent the diversity of the general population, Hepburn said, and were done “in anticipation of trying to increase confidence” among the public. For example, at least 25% of clinical trial participants are over the age of 65, a population not normally used for clinical trials but one at greater risk from COVID-19, he noted.

The number of doses needed for immunizations is “really a moving target, which is not necessarily a bad thing,” Hepburn said. “The consistency and cadence of manufacturing improves over time, and more doses are available than we thought would be available last week.”

OWS’ project team asks for “more doses on a daily basis,” he noted.

Armed services research efforts prior to the pandemic will allow for future innovation and speed of vaccine and therapeutics development, Hepburn said.

“If we hadn’t made those investments 10 years ago, there is no way we could have achieved the speed” of going from research and development, to candidates, to clinical trials, to approval and distribution, he said.

He noted that the DOD’s “clinical research enterprise led us to be involved in the enrollment right now in the AstraZeneca clinical trials.”

He called the department’s research enterprise “an incredibly powerful tool to confront 21st century threats,” and that “this is the new standard for rapid product development, and will apply not only to pandemics but also to develop product for combat health in half the time. Imagine how fast we could go in force protection” using the new paradigm, he said.

During a question and answer session, Hepburn emphasized that the AMSUS audience “needs to remind people at the DOD and in the community at large how well DOD can work” when confronted by new viral or other national security and health care threats.

“One of the most important lessons learned is the value of military leadership” in overcoming obstacles at a rapid clip, he said, noting the DOD “didn’t take over a public health initiative, but collaborated on a project that involved not only what we’re doing for the American people but also globally.”

You also may be interested in...

Pregnancy Health Alert: COVID-19 Vaccine is Strongly Recommended

Article
10/20/2021
Pregnant women gets the COVID-19 vaccine

Get vaccinated for COVID-19 if you’re pregnant or trying, DOD and CDC and advise.

Recommended Content:

COVID-19 Vaccine Toolkit | Women's Health

More Than 95% of Active Duty Have Received COVID-19 Vaccine

Article
10/15/2021
Female hospital corpsman gives a COVID-19 vaccine injection to a sailor in her left arm

Service members continue to line up for COVID-19 vaccinations.

Recommended Content:

COVID-19 Vaccine Efforts | Coronavirus | COVID-19 Information for Military Treatment Facility Directors

USECAF receives insight into COVID19 vaccinations at Reserve wing

Article Around MHS
10/8/2021
Under Secretary of the Air Force Gina Ortiz Jones visits with 433rd Airlift Wing members at Wilford Hall Ambulatory Surgical Center, Joint Base San Antonio-Lackland, Texas, Oct. 2, 2021.

Under Secretary of the Air Force Gina Ortiz Jones visited the 433rd Airlift Wing here to meet with Reserve Citizen Airmen leaders on mandatory COVID-19 vaccination efforts, Oct. 2, 2021.

Recommended Content:

COVID-19 Vaccine Efforts | Coronavirus

Mask Mouth Does Not Exist, Dentists Say

Article
10/6/2021
A bunch of children wearing face masks walk on a city street.

Mask mouth doesn’t exist, Internet chatter to the contrary, dentists say.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus

Compassionate Caring with COVID Vax Commitment

Article Around MHS
10/6/2021
A  female doctor poses for a photo.

When pregnant patients have an appointment with Lt. Cmdr. Megan Northup at Naval Hospital Bremerton, they get more than a qualified and caring OB/GYN physician.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

Health Promotion duo optimizes health on Incirlik Air Base

Article Around MHS
9/30/2021
Air Force Capt. Sydney Sloan, 39th Operational Medical Readiness Squadron health promotion element chief (right), and Air Force Senior Airman Gloriann Manapsal, 39th Operational Medical Readiness Squadron health promotion technician (left), promote making healthy choices at the Sultan’s Inn Dining Facility on Incirlik Air Base, Turkey.

The 39th Operation Medical Readiness Squadron health promotion team provides and integrates evidence-based programs to optimize the health and readiness, even during these unprecedented times.

Recommended Content:

Health Readiness | Total Force Fitness | Coronavirus

COVID-19 Booster Shots are Now Available – What You Need to Know

Article
9/30/2021
Containers of the Pfizer COVID-19 vaccine. Each vial contains six doses for vaccination against the COVID-19 virus.

Booster shots are now recommended for millions of people – but many others will have to wait for additional approvals.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

Myths & facts about the vax - debunking common COVID-19 vaccine myths

Article
9/29/2021
Myths and facts about the vax

The COVID-19 vaccine has been mandated across the Department of Defense and despite its demonstrated effectiveness and safety, a host of myths have left some Airmen and Guardians hesitant to receive it. While social media posts and some news outlets may make it harder to keep up with what is fact or fiction, the science is clear … approved COVID-19 vaccines work.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

Retired colonel leads Fort Irwin COVID response mission

Article Around MHS
9/28/2021
Army Col. Richard Hopkins, the COVID-19 response coordinator with Weed Army Community Hospital, collects paperwork from a Soldier who received the COVID-19 vaccine at a vaccination event.

Retired Army Col. Richard Hopkins volunteered under the Army’s COVID-19 Retiree Recall Program to return to service as the COVID-19 response coordinator for Weed Army Community Hospital and Fort Irwin, California.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

ARNORTH military support to FEMA begins in Tennessee, continues in five states

Article Around MHS
9/24/2021
Prepared COVID-19 vaccine shots wait to be administered to an Airman. Members of the 134th Air Refueling Wing were eligible to receive their COVID-19 vaccines during Unit Training Assembly here May 2nd, 2021.

At the request of the Federal Emergency Management Agency, approximately 20 military medical personnel deployed to Tennessee to support civilian healthcare workers treating COVID-19 patients in local hospitals.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

DODEA Schools Keeps On With In-Person Classes, and Fall Sports, Too

Article
9/23/2021
Kids playing football

DODEA schools are striving to continue in-person learning in the 2021-22 school year.

Recommended Content:

Children's Health | Coronavirus

COVID-19 can lead to long-term health concerns

Article Around MHS
9/23/2021
Debra Lamb, a 30-year civil service veteran at Ft. Carson, contracted the COVID-19 virus late in 2020 and experienced a harrowing ordeal before partially recovering months later.

Debra Lamb, a 30-year civil service veteran at Ft. Carson, contracted the COVID-19 virus late in 2020 and experienced a harrowing ordeal before partially recovering months later.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

6th Medical Group Delivers Mandatory Vaccines

Article Around MHS
9/21/2021
An Airman from the 6th Medical Group prepares a COVID-19 vaccine for distribution at MacDill Air Force Base, Florida.

Airmen from the 6th Medical Group began redistributing doses of the COVID-19 vaccine at MacDill Air Force Base, Florida, on Sept. 9, 2021. This comes after the Secretary of Defense issued a memorandum on Aug. 23, 2021, mandating all active duty personnel to be fully vaccinated against COVID-19.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

Get to Know the Vaccines

Publication
9/17/2021

A graphic showing the types of vaccines, how they work, and safety monitoring of the vaccines. Includes the MHS and TRICARE logos on the bottom right, and includes graphics of scientists, doctors, and patients.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines

Get to know the COVID19 Vaccines

Publication
9/17/2021

Get to know the vaccines – they do not contain the live virus, they do not interact with our DNA, and have been tested rigorously.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 43

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.